Congestive Heart Failure in the Community

Author:

Senni Michele1,Tribouilloy Christophe M.1,Rodeheffer Richard J.1,Jacobsen Steven J.1,Evans Jonathan M.1,Bailey Kent R.1,Redfield Margaret M.1

Affiliation:

1. From the Division of Cardiovascular Diseases and Internal Medicine (M.S., C.M.T., R.J.R., M.M.R.), the Department of Health Sciences Research (S.J.J., K.R.B.), and the Division of Community Internal Medicine (J.M.E.), Mayo Clinic and Mayo Foundation, Rochester, Minn.

Abstract

Background —Data are limited regarding the classification and prognosis of patients with congestive heart failure (CHF) in the community. Methods and Results —Using the resources of the Rochester Epidemiology Project, we evaluated all patients receiving a first diagnosis of CHF in Olmsted County, Minnesota, in 1991 (n=216). Among these patients, 88% were ≥65 years and 49% were ≥80 years of age. The prognosis of patients with a new diagnosis of CHF was poor; survival was 86±2% at 3 months, 76±3% at 1 year, and 35±3% at 5 years. Of the 216 patients, 137 (63%) had an assessment of ejection fraction. In these patients, systolic function was preserved (ejection fraction ≥50%) in 59 (43%) and reduced (ejection fraction <50%) in 78 (57%). Survival adjusted for age, sex, NYHA class, and coronary artery disease was not significantly different between patients with preserved and those with reduced systolic function (relative risk, 0.80; P =0.369). ACE inhibitors were used in only 44% of the total population with CHF. Conclusions —The present study reports the clinical characteristics and natural history of CHF as it presents in the community in the vasodilator era. CHF is a disease of the “very elderly,” frequently occurs in the setting of normal ejection fraction, and has a poor prognosis, regardless of the level of systolic function. Diagnostic and therapeutic methods are underused in the community.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference40 articles.

1. National Heart Lung and Blood Institute. Morbidity and Mortality: Chartbook on Cardiovascular Lung and Blood Disease—1992 . Bethesda Md: US Department of Health and Human Service; 1992.

2. Epidemiology of congestive heart failure

3. Yusuf S Thom T Abbott RD. Changes in hypertension treatment and in congestive heart failure mortality in the United States. Hypertension . 1989;13(suppl 5):I-74–I-79.

Cited by 901 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3